Literature DB >> 2444623

Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen.

H I Rautelin1, T U Kosunen.   

Abstract

Campylobacter antibodies of the immunoglobulin G (IgG), IgM, and IgA classes were determined by enzyme immunoassay with acid glycine extract antigen in patients and controls involved in two Campylobacter outbreaks and in 266 unselected patients with acute enteritis. The assay showed a specificity of 99% for each immunoglobulin class in sera from 200 healthy blood donors. Elevated Campylobacter antibody titers were shown in 97% of stool culture-positive patients involved in the outbreaks. Rapid changes of IgA and IgM Campylobacter antibodies were typical of the early phase of serologic response in the outbreaks and thus offered the best diagnostic value in the serologic diagnosis of acute campylobacteriosis. In unselected patients with acute enteritis, the assay revealed elevated Campylobacter antibody titers in 37 patients, of whom only 12 had had positive Campylobacter stool cultures. In the sera of patients with other bacterial findings in addition to high titers of Campylobacter antibodies, no cross-reacting antibodies were found, but there was evidence of several mixed infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444623      PMCID: PMC269373          DOI: 10.1128/jcm.25.10.1944-1951.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

2.  Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens.

Authors:  J L Penner; J N Hennessy
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

3.  [Serologic diagnosis of human campylobacter infections].

Authors:  J Mosimann; M Jung; G Schär; V Bonifas; I Heinzer; S Brunner; G Hermann; R A Lambert
Journal:  Schweiz Med Wochenschr       Date:  1981-06-06

4.  Serological response to Campylobacter jejuni/coli infection.

Authors:  D M Jones; J Eldridge; B Dale
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

5.  Campylobacter enteritis in 188 hospitalized patients.

Authors:  T Pitkänen; A Pönkä; T Pettersson; T U Kosunen
Journal:  Arch Intern Med       Date:  1983-02

6.  Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: II. Serological findings.

Authors:  T U Kosunen; T Pitkänen; T Pettersson; A Pönkä
Journal:  Infection       Date:  1981       Impact factor: 3.553

7.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

8.  Acid and alkaline Campylobacter extracts in the demonstration of antibody response in hyperimmunized rabbits.

Authors:  H Rautelin
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-04

9.  Campylobacter enteritis associated with canine infection.

Authors:  M Blaser; J Cravens; B W Powers; W L Wang
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

10.  Superficial antigens of Campylobacter (Vibrio) fetus: characterization of antiphagocytic component.

Authors:  E C McCoy; D Doyle; K Burda; L B Corbeil; A J Winter
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

View more
  9 in total

1.  Isolation of a urease positive thermophilic variant of Campylobacter lari from a patient with urinary tract infection.

Authors:  M C Bézian; G Ribou; C Barberis-Giletti; F Mégraud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

2.  Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

Authors:  M A Strid; J Engberg; L B Larsen; K Begtrup; K Mølbak; K A Krogfelt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

3.  Prospective study of Campylobacter jejuni infection in Chilean infants evaluated by culture and serology.

Authors:  G Figueroa; H Galeno; M Troncoso; S Toledo; V Soto
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

4.  Surveillance of acute flaccid paralysis in Italy: 1996-1997. AFP Study Group. Acute flaccid paralysis.

Authors:  L Fiore; F Novello; P Simeoni; C Amato; L Vellucci; D De Stefano; M E Grandolfo; I Luzzi
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

5.  Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide.

Authors:  I Nachamkin; X H Yang
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

6.  Waterborne outbreak of Campylobacter enteritis after outdoors infantry drill in Utti, Finland.

Authors:  M Aho; M Kurki; H Rautelin; T U Kosunen
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

7.  Identification of an antigen common to different species of the genus Campylobacter.

Authors:  S D Mills; L A Kurjanczyk; J L Penner
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

8.  Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.

Authors:  Beth D Kirkpatrick; Caroline E Lyon; Chad K Porter; Alex C Maue; Patricia Guerry; Kristen K Pierce; Marya P Carmolli; Mark S Riddle; Catherine J Larsson; Douglas Hawk; Elizabeth A Dill; A Fingar; Frederic Poly; Kelly A Fimlaid; Fahmida Hoq; David R Tribble
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

9.  Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study.

Authors:  Andreas Jansen; Klaus Stark; Jan Kunkel; Eckart Schreier; Ralf Ignatius; Oliver Liesenfeld; Dirk Werber; Ulf B Göbel; Martin Zeitz; Thomas Schneider
Journal:  BMC Infect Dis       Date:  2008-10-22       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.